Sandbox:Reddy 2: Difference between revisions
(Blanked the page) |
No edit summary |
||
Line 1: | Line 1: | ||
Hospitalized patients | |||
{| class="wikitable" | |||
!Infection | |||
! | |||
!Organisms | |||
!First DOC | |||
!Alternative | |||
! | |||
|- | |||
| rowspan="2" |'''Osteomyelitis''' | |||
|Presumed hematogenous source or contiguous without vascular insufficiency | |||
|''S. aureus'' | |||
|Vancomycin | |||
|Vanc | |||
|If ''S. aureus'' is methicillin-susceptible then cefazolin 2 g IV q8h or nafcillin 2 g IV q4h are the antibiotics of choice. | |||
Obtain bone biopsy to determine microbiologic cause prior to initiation of antimicrobial therapy if blood cultures are negative and patient clinically stable. | |||
|- | |||
|With vascular insufficiency or diabetes mellitus (e.g. severe diabetic foot ulcer) | |||
|''S. aureus'' | |||
Enterobacteriaceae | |||
Anaerobes | |||
|'''Vancomycin''' | |||
PLUS ONE OF: | |||
'''Piperacillin/Tazobactam'''ID-R: SFGH 4.5 g IV q6-8h | |||
OR | |||
'''Ertapenem''' 1 g IV daily | |||
|For '''severe''' PCN allergy: | |||
'''Vancomycin''' | |||
PLUS ONE OF: | |||
'''Ciprofloxacin'''ID-R: VASF 400 mg IV q12h | |||
OR | |||
'''Levofloxacin''' ID-R: VASF 750 mg IV daily | |||
OR | |||
'''Aztreonam''' ID-R: SFGH 2 g IV q8h | |||
ALL WITH OR WITHOUT: | |||
'''Metronidazole'''500 mg IV q8h (if patient critically ill) | |||
|Other organisms are possible, esp. with hardware microbiologic diagnosis and ID consultation recommended | |||
Obtain bone biopsy to determine microbiologic cause prior to initiation of antimicrobial therapy if patient clinically stable | |||
Once stable, switch to oral antibiotics based on susceptibility results. | |||
|- | |||
|'''Septic Arthritis''' | |||
| | |||
|''S. aureus'' | |||
''Streptococci spp.'' | |||
''N. gonorrhoeae'' | |||
''Enterobacteriaceae (rarely)'' | |||
|'''Vancomycin''' | |||
PLUS | |||
'''Ceftriaxone'''1 g IV daily | |||
|For '''severe''' PCN allergy: | |||
'''Vancomycin''' | |||
PLUS ONE OF: | |||
'''Ciprofloxacin'''ID-R: VASF 400 mg IV q12h | |||
OR | |||
'''Levofloxacin''' ID-R: VASF 500 mg IV daily | |||
OR | |||
'''Aztreonam'''ID-R: SFGH 2 g IV q8h if gonococcus is strongly suspected | |||
|Gram stain recommended to guide therapy. | |||
Narrow coverage to microbiologically confirmed pathogens. | |||
|} |
Revision as of 18:56, 29 June 2017
Hospitalized patients
Infection | Organisms | First DOC | Alternative | ||
---|---|---|---|---|---|
Osteomyelitis | Presumed hematogenous source or contiguous without vascular insufficiency | S. aureus | Vancomycin | Vanc | If S. aureus is methicillin-susceptible then cefazolin 2 g IV q8h or nafcillin 2 g IV q4h are the antibiotics of choice.
Obtain bone biopsy to determine microbiologic cause prior to initiation of antimicrobial therapy if blood cultures are negative and patient clinically stable. |
With vascular insufficiency or diabetes mellitus (e.g. severe diabetic foot ulcer) | S. aureus
Enterobacteriaceae Anaerobes |
Vancomycin
PLUS ONE OF: Piperacillin/TazobactamID-R: SFGH 4.5 g IV q6-8h OR Ertapenem 1 g IV daily |
For severe PCN allergy:
Vancomycin PLUS ONE OF: CiprofloxacinID-R: VASF 400 mg IV q12h OR Levofloxacin ID-R: VASF 750 mg IV daily OR Aztreonam ID-R: SFGH 2 g IV q8h ALL WITH OR WITHOUT: Metronidazole500 mg IV q8h (if patient critically ill) |
Other organisms are possible, esp. with hardware microbiologic diagnosis and ID consultation recommended
Obtain bone biopsy to determine microbiologic cause prior to initiation of antimicrobial therapy if patient clinically stable Once stable, switch to oral antibiotics based on susceptibility results. | |
Septic Arthritis | S. aureus
Streptococci spp. N. gonorrhoeae Enterobacteriaceae (rarely) |
Vancomycin
PLUS Ceftriaxone1 g IV daily |
For severe PCN allergy:
Vancomycin PLUS ONE OF: CiprofloxacinID-R: VASF 400 mg IV q12h OR Levofloxacin ID-R: VASF 500 mg IV daily OR AztreonamID-R: SFGH 2 g IV q8h if gonococcus is strongly suspected |
Gram stain recommended to guide therapy.
Narrow coverage to microbiologically confirmed pathogens. |